M
Michael T. McCurdy
Researcher at University of Maryland, Baltimore
Publications - 115
Citations - 2464
Michael T. McCurdy is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Angiotensin II & Shock (circulatory). The author has an hindex of 21, co-authored 108 publications receiving 1460 citations. Previous affiliations of Michael T. McCurdy include Jacobi Medical Center.
Papers
More filters
Journal ArticleDOI
Angiotensin II for the Treatment of Vasodilatory Shock.
Ashish Khanna,Shane W. English,Xueyuan S. Wang,Kealy R. Ham,James A. Tumlin,Harold M. Szerlip,Laurence W. Busse,Laith Altaweel,Timothy E Albertson,Caleb Mackey,Michael T. McCurdy,David W. Boldt,Stefan N. Chock,Paul J Young,Kenneth Krell,Richard G. Wunderink,Marlies Ostermann,Raghavan Murugan,Michelle N. Gong,Rakshit Panwar,Johanna Hästbacka,Raphael Favory,Balasubramanian Venkatesh,B. Taylor Thompson,Rinaldo Bellomo,Jeffrey B. Jensen,Jeffrey B. Jensen,Stew Kroll,Lakhmir S. Chawla,George F. Tidmarsh,George F. Tidmarsh,George F. Tidmarsh,Adam M. Deane +32 more
TL;DR: Angiotensin II effectively increased blood pressure in patients with vasodilatory shock that did not respond to high doses of conventional vasopressors.
Journal ArticleDOI
Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019.
Jonathan H Chow,Ashish Khanna,Ashish Khanna,Shravan Kethireddy,David Yamane,Andrea R. Levine,Amanda M. Jackson,Michael T. McCurdy,Ali Tabatabai,Gagan Kumar,Paul H. Park,Ivy Benjenk,Jay Menaker,Nayab Ahmed,Evan Glidewell,Elizabeth Presutto,Shannon Cain,Naeha Haridasa,Wesley Field,Jacob G. Fowler,Duy Trinh,Kathleen N. Johnson,Aman Kaur,Amanda Lee,Kyle Sebastian,Allison Ulrich,Salvador Peña,Ross Carpenter,S. Sudhakar,Pushpinder Uppal,Benjamin T Fedeles,Aaron N. Sachs,Layth Dahbour,William A. Teeter,Kenichi A. Tanaka,Samuel M. Galvagno,Daniel Herr,Thomas M. Scalea,Michael A. Mazzeffi +38 more
TL;DR: Aspirin use may be associated with improved outcomes in hospitalized COVID-19 patients, however, a sufficiently powered randomized controlled trial is needed to assess whether a causal relationship exists between aspirin use and reduced lung injury and mortality in patients.
Journal ArticleDOI
SARS-CoV-2 infection and persistence in the human body and brain at autopsy
Sydney Stein,Sabrina Ramelli,Alison Grazioli,Joon-Yong Chung,Manmeet Singh,Claude Kwe Yinda,Clayton W. Winkler,Junfeng Sun,James Dickey,Kris Ylaya,Sung Hee Ko,Andrew Platt,Peter D. Burbelo,Martha Quezado,Stefania Pittaluga,M. Purcell,Vincent J. Munster,Frida Belinky,Marcos J Ramos-Benitez,Eli Boritz,Izabella A. Lach,Daniel Herr,Joseph Rabin,Kapil K. Saharia,Ronson J. Madathil,Ali Tabatabai,Shahabuddin Soherwardi,Michael T. McCurdy,Karin E. Peterson,Jeffrey I. Cohen,Emmie de Wit,Kevin M. Vannella,Stephen M. Hewitt,David E. Kleiner,Daniel S. Chertow +34 more
TL;DR: In this paper , the authors carried out complete autopsies on 44 patients who died with COVID-19, with extensive sampling of the central nervous system in 11 of these patients, to map and quantify the distribution, replication and cell-type specificity of SARS-CoV-2 across the human body, including the brain, from acute infection to more than seven months following symptom onset.
Journal ArticleDOI
Expert consensus statements for the management of COVID-19-related acute respiratory failure using a Delphi method.
Prashant Nasa,Elie Azoulay,Ashish Khanna,Ravi Jain,Sachin Gupta,Yash Javeri,Deven Juneja,Pradeep Rangappa,Krishnaswamy Sundararajan,Waleed Alhazzani,Massimo Antonelli,Yaseen M. Arabi,Jan Bakker,Jan Bakker,Jan Bakker,Laurent Brochard,Adam M. Deane,Bin Du,Sharon Einav,Andrés Esteban,Ognjen Gajic,Samuel M. Galvagno,Claude Guérin,Samir Jaber,Gopi C. Khilnani,Younsuck Koh,Jean-Baptiste Lascarrou,Flávia Ribeiro Machado,Manu L N G Malbrain,Jordi Mancebo,Michael T. McCurdy,Brendan McGrath,Sangeeta Mehta,Armand Mekontso-Dessap,Mervyn Mer,Michael Nurok,Pauline K. Park,Paolo Pelosi,John Victor Peter,Jason Phua,David Pilcher,Lise Piquilloud,Peter Schellongowski,Marcus J. Schultz,Marcus J. Schultz,Marcus J. Schultz,Manu Shankar-Hari,Manu Shankar-Hari,Suveer Singh,Massimiliano Sorbello,Ravindranath Tiruvoipati,Andrew A. Udy,Tobias Welte,Sheila Nainan Myatra +53 more
TL;DR: Using a Delphi process, an international panel of experts developed clinical practice statements on the respiratory management of COVID-19-related acute respiratory failure (C-ARF) in areas where evidence is absent or limited as discussed by the authors.
Journal ArticleDOI
COVID-19 and the RAAS-a potential role for angiotensin II?
TL;DR: As more is learned about the SARS-CoV-2 virus, some noteworthy conclusions regarding currently available ancillary “therapies” which may affect the natural history of the COVID-19 infection are drawn.